Old Web
English
Sign In
Acemap
>
Paper
>
Postrelapse MS Treatment with Alemtuzumab Better than SC IFN- -1a
Postrelapse MS Treatment with Alemtuzumab Better than SC IFN- -1a
2014
B. Hoyle
F Barkhof
Keywords:
Cancer research
Alemtuzumab
Medicine
Oncology
Internal medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]